[et_pb_section bb_built=”1″][et_pb_row][et_pb_column type=”4_4″][et_pb_text _builder_version=”3.13.1″]
Today there are advances in engineering, biomedical, robotics, electronics and nanotechnology to create organs that replace the functioning of the body.
For example, the artificial pancreas for patients with type I diabetes who continuously monitors blood glucose levels and releases insulin to the body automatically when necessary in a single process.
The new research proposes a definitive, less invasive and much more effective solution for patients with type 1 diabetes, since it continuously inspects glucose and the programmed algorithms decide when and how much insulin should be administered.
The artificial pancreas is a safe and in progress technology to help people with type I diabetes control blood glucose levels, that is, it fulfills functions of a healthy pancreas, reduces the time in hyperglycemia and in hypoglycemia, compared to other types of therapy.
The artificial pancreas project as a workable technology, have been reported clinical studies of a total of 20 processes in the world approximately. The level of automation, the type of control algorithm, the hormones used and the scope of the clinical studies implemented allow us to differentiate the different artificial pancreas systems in development.
These and other innovations are also possible in Pharmamedic.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
